Technical Analysis for ORMP - Oramed Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade D 3.18 1.60% 0.05
ORMP closed up 1.6 percent on Wednesday, October 23, 2019, on 36 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ORMP trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Up 3 Days in a Row Strength 0.00%
50 DMA Resistance Bearish 1.60%
Crossed Above 20 DMA Bullish 1.60%
MACD Bullish Signal Line Cross Bullish 1.60%
Bollinger Band Squeeze Range Contraction 1.60%
Narrow Range Bar Range Contraction 1.60%

Older signals for ORMP ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Oramed Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. The company's products primarily comprise ORMD0801, an oral insulin capsule that is in Phase II clinical trials for the treatment of diabetes; and ORMD0901, an analog for GLP-1 gastrointestinal hormone that is in per-clinical trials. Its portfolio of product candidates is based on intellectual property that allows for the protection of proteins and polypeptides in the stomach, and for their absorption through the gastrointestinal wall. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Jerusalem, Israel.
Medicine Chemistry Pharmaceutical Pharmaceutical Industry Diabetes Medication Pharmaceutical Industry In China Endocrine System Dosage Forms Insulin Peptide Hormones Treatment Of Diabetes Glucagon Like Peptide 1 Tablet Pharmaceutical Solutions
Is ORMP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.69
52 Week Low 2.78
Average Volume 54,542
200-Day Moving Average 3.3644
50-Day Moving Average 3.1453
20-Day Moving Average 3.112
10-Day Moving Average 3.108
Average True Range 0.1459
ADX 12.98
+DI 19.7504
-DI 12.8162
Chandelier Exit (Long, 3 ATRs ) 2.9297
Chandelier Exit (Short, 3 ATRs ) 3.4077
Upper Bollinger Band 3.2213
Lower Bollinger Band 3.0027
Percent B (%b) 0.81
BandWidth 7.024422
MACD Line -0.013
MACD Signal Line -0.0195
MACD Histogram 0.0065
Fundamentals Value
Market Cap 42.36 Million
Num Shares 13.3 Million
EPS -0.95
Price-to-Earnings (P/E) Ratio -3.35
Price-to-Sales 59.88
Price-to-Book 6.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.28
Resistance 3 (R3) 3.27 3.23 3.26
Resistance 2 (R2) 3.23 3.20 3.23 3.26
Resistance 1 (R1) 3.20 3.19 3.21 3.21 3.25
Pivot Point 3.16 3.16 3.17 3.17 3.16
Support 1 (S1) 3.14 3.14 3.15 3.15 3.11
Support 2 (S2) 3.10 3.12 3.10 3.10
Support 3 (S3) 3.07 3.10 3.10
Support 4 (S4) 3.08